type here...
type here...
START FREE TRIAL

Healthcare

Technology & AIInformation TechnologyHealthcareIndustrialsConsumer & RetailEnergy

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

Healthcare Ishan Majumdar -
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private equity firm Patient Square Capital....

GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?

Healthcare Ishan Majumdar -
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm specializing in AI-powered brain imaging...
spot_imgspot_img

Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit

Healthcare Ishan Majumdar -
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...

Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism

Healthcare Ishan Majumdar -
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...

Alcon’s Purchase Of STAAR Signals A New Chapter In Surgical Eye Care

Healthcare Ishan Majumdar -
Alcon’s recent agreement to acquire STAAR Surgical for $28 per share—representing a 59% premium to STAAR’s 90-day VWAP and...

Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!

Healthcare Ishan Majumdar -
Waters Corporation has officially entered a new phase of its growth journey with the $17.5 billion acquisition of Becton...

Bausch Health Strikes Bold With Durect Buy: A Strategic Bet On Liver Therapies?

Healthcare Ishan Majumdar -
Bausch Health Companies (NYSE:BHC) has made headlines with its definitive agreement to acquire liver-focused biotech Durect Corporation (NASDAQ:DRRX) for...

Axogen In Play? Here’s Why A Buyout Makes Sense At $18/Share

Healthcare Ishan Majumdar -
Axogen, Inc. (NASDAQ: AXGN) saw its stock jump nearly 4% after reports surfaced that the company is exploring a...
Load more

test

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

Healthcare Ishan Majumdar -
Premier Inc, a healthcare group purchasing and technology company, has recently become the subject of acquisition interest from private...

GE Healthcare’s Neurology Bet: Can The Icometrix Acquisition Unlock The Alzheimer’s Diagnosis Market?

Healthcare Ishan Majumdar -
GE HealthCare has deepened its push into precision medicine with a strategic agreement to acquire icometrix, a Belgium-based firm...

Jamf Holding’s $1.4 Billion Shakeup: Citigroup Tapped As Vista Plots Its Exit

Healthcare Ishan Majumdar -
Jamf Holding Corp., a leading Apple-focused device management and security software provider, has become the subject of renewed M&A...

Kenvue Crashing?—New RFK Jr. Report May Blame Tylenol Use In Pregnancy For Autism

Healthcare Ishan Majumdar -
Shares of Kenvue Inc., maker of Tylenol, dropped roughly 10% in early September 2025 after media reports—primarily from The...

Alcon’s Purchase Of STAAR Signals A New Chapter In Surgical Eye Care

Healthcare Ishan Majumdar -
Alcon’s recent agreement to acquire STAAR Surgical for $28 per share—representing a 59% premium to STAAR’s 90-day VWAP and...

Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition!

Healthcare Ishan Majumdar -
Waters Corporation has officially entered a new phase of its growth journey with the $17.5 billion acquisition of Becton...

Bausch Health Strikes Bold With Durect Buy: A Strategic Bet On Liver Therapies?

Healthcare Ishan Majumdar -
Bausch Health Companies (NYSE:BHC) has made headlines with its definitive agreement to acquire liver-focused biotech Durect Corporation (NASDAQ:DRRX) for...

Axogen In Play? Here’s Why A Buyout Makes Sense At $18/Share

Healthcare Ishan Majumdar -
Axogen, Inc. (NASDAQ: AXGN) saw its stock jump nearly 4% after reports surfaced that the company is exploring a...

How Abbvie’s $1B Gilgamesh Bet Could Supercharge Its Next Growth Chapter

Healthcare Ishan Majumdar -
AbbVie’s reported discussions to acquire Gilgamesh Pharmaceuticals for approximately $1 billion mark the latest twist in the company’s aggressive...

Test

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Super Micro Stock Surges After Game-Changing AI Deal With Nokia

0
Shares of Super Micro Computer (NASDAQ: SMCI) rallied sharply...

Sentinelone Eyes Observo AI: A $1 Billion Cybersecurity Power Play In The Making?

0
SentinelOne’s recent earnings call made headlines with a major...

Paramount & Skydance’s Bold $70 Billion Gamble: Ellison-Backed Bid For Warner Bros. Discovery

0
Paramount Skydance is preparing to launch one of the...

Premier Inc. Draws Buyout Interest From Patient Square Capital — Here’s Why This Deal Could Happen

0
Premier Inc, a healthcare group purchasing and technology company,...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2025 Baptista Research. All rights reserved.